Tæknilegar niðurstöður What ImmuPharma’s Moves Reveal About Peptide CMC Strategy Sep 3, 2026 Lestu meira
Sérsniðin peptíðmyndun What Lonza’s Margin Hike and ADC Deal Mean for Peptide Developers Sep 3, 2026 Lestu meira
Sérsniðin peptíðmyndun Multifunctional Peptide Hydrogel Design: Adhesion, Antimicrobial, Stability Sep 2, 2026 Lestu meira
